Compound information
- Natural Products
- ZC1449668
- Molecular Formula
- C20H23N5O2
- Molecular Weight
- 365.185174976 g/mol
- Structure
-
- IUPAC Name
- N-(1H-indazol-5-yl)-4-[(3-methoxyphenyl)methyl]piperazine-1-carboxamide
- InChI
- InChI=1S/C20H23N5O2/c1-27-18-4-2-3-15(11-18)14-24-7-9-25(10-8-24)20(26)22-17-5-6-19-16(12-17)13-21-23-19/h2-6,11-13H,7-10,14H2,1H3,(H,21,23)(H,22,26)
- InChI Key
- CTGKPPULCVNYDI-UHFFFAOYSA-N
- SMILES
- COc1cccc(CN2CCN(C(=O)Nc3ccc4[nH]ncc4c3)CC2)c1
- Source
- ZINC000299797849
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 4 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 73.49 Å2 | LogP | 2.748 |
LogS | -3.827 | LogD | 3.287 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.839 | Pgp substrate | 0.962 |
HIA | 0.955 | F20 % | 0.925 |
F30 % | 0.347 | Caco-2 | -5.124 |
MDCK | -5.384 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.554 | PPB | 86.739 |
VD | 1.449 | Fu | 0.852 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.082 | CYP1A2 substrate | 0.802 |
CYP2A6 substrate | 0.55 | CYP2B6 substrate | 0.608 |
CYP2C19 inhibitor | 0.927 | CYP2C19 substrate | 0.913 |
CYP2C8 substrate | 0.856 | CYP2C9 inhibitor | 0.487 |
CYP2C9 substrate | 0.025 | CYP2D6 inhibitor | 0.959 |
CYP2D6 substrate | 0.988 | CYP2E1 substrate | 0.728 |
CYP3A4 inhibitor | 0.918 | CYP3A4 substrate | 0.98 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.776 | CL | 9.921 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.543 | Hepatotoxicity | 0.684 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.575 |
FDAMDD | 0.827 | Skin Sensitization | 0.974 |
Carcinogenicity | 0.585 | Eye Corrosion | 0.005 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.98 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.708 | IGC50 | 3.07 |
LC50FM | -9.197 | LC50DM | -6.939 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.285 | NR-AR-LBD | 0.257 |
NR-AhR | 0.893 | NR-Aromatase | 0.038 |
NR-ER | 0.453 | NR-ER-LBD | 0.315 |
NR-PPAR-gamma | 0.202 | SR-ARE | 0.871 |
SR-ATAD5 | 0.56 | SR-HSE | 0.146 |
SR-MMP | 0.029 | SR-p53 | 0.112 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.